Replies to post #226609 on Biotech Values

[DewDiligence]

On the 3Q19 CC, GILD mentioned the “predictability” of the HCV business on several occasions (https://finance.yahoo.com/news/edited-transcript-gild-earnings-conference-082839398.html ). So, GILD and ABBV are plainly not expecting any new price erosion.